MSMesbah Shams

Mesbah Shams

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mesbah Shams has a total of 125 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chlorella vulgaris and Lactobacillus casei Combination Therapy Attenuates Testicular Endoplasmic Reticulum Stress and Dysfunction in a C57BL/6 Mouse Model of NAFLD

    by Farhad Koohpeyma, Sanaz Dastghaib, Forough Saki, Nima Montazeri-Najafabady, Zahra Moayedfard, Naeimehossadat Asmarian, Pooneh Mokarram, Negar Azarpira, Mesbah Shams

    Nonalcoholic fatty liver disease (NAFLD) is a common metabolic disorder closely associated with increased oxidative stress and a range of chronic conditions, including male infertility. Previous studies have indicated that Chlorella vulgaris (CV) and Lactobacillus casei (LBC) exert beneficial effects on NAFLD. This study aimed to evaluate the impact of CV and LBC supplementation on testicular dysfunction in a high-fat diet (HFD)-induced NAFLD mouse model, with a focus on the unfolded protein response (UPR) signaling pathway. Male C57BL/6 mice were randomly assigned to five groups: control, NAFLD (HFD for 8 weeks), NAFLD + CV (8 weeks of HFD, followed by 35 days of normal diet supplemented with CV 150 mg/kg), NAFLD + LBC (HFD followed by 35 days of LBC 108 CFU/ml), and NAFLD + CV+LBC (combined treatment). Total antioxidant capacity (TAC), malondialdehyde (MDA), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels were assessed. Expression of UPR- and apoptosis-related genes was quantified, and histopathological evaluations, including the modified Johnson scoring system, were conducted. CV and LBC supplementation significantly increased serum TAC and testosterone, while reducing MDA, LH, and FSH levels (p < 0.05). Treated groups showed upregulation of UPR genes (GRP78, IRE1α, PERK, ATF6) and downregulation of pro-apoptotic markers (Caspase-3, BAX/Bcl-2 ratio). Histopathological analyses revealed improved testicular structure and sperm parameters, particularly in the combined treatment group. CV and LBC ameliorated the testicular dysfunction in NAFLD by mitigating oxidative stress and modulating UPR and apoptosis pathways. These findings suggest a promising therapeutic strategy warranting further clinical investigation.

  • Open Access

    Dorema Aucheri Extract Modulates Unfolded Protein Response Pathways in Streptozotocin‐Induced Diabetic Rats: A Protective Role Against Hepatic Damage

    by Alireza Raeisi, Farhad Koohpeyma, Roozbeh Kiani, Somayeh Igder, Amir Maleksabet, Nima Rahimikashkooli, Narges Rezaei, Mesbah Shams, Sanaz Dastghaib

    Purpose: Endoplasmic reticulum stress (ERS) plays a pivotal role in the development of diabetes‐induced liver damage. Under elevated ERS, the unfolded protein response (UPR) balances cellular survival and death. There may be a preventive effect of herbal extracts against problems associated with diabetes. In this study, the effects of a hydroalcoholic extract from Dorema aucheri on liver damage, ERS, and UPR in diabetic rats were assessed. Methods: There were five groups of rats, each including six rats. A 60 mg/kg intraperitoneal injection of streptozotocin (STZ) was used to cause diabetes. Every day, 1 mL of normal saline was given to the control groups, who were normal and diabetic. For 28 days, three diabetic groups were given oral gavage doses of 250/500 mg/kg of D. aucheri extract and 500 mg/kg of metformin daily. Serum and liver samples were used to assess blood glucose, liver enzymes, oxidative stress, inflammatory markers, and antioxidant levels after treatment. Furthermore, liver tissue pathology, stereology, and gene expression were examined. Results: Compared to the diabetic groups, the treated groups exhibited a significant decrease in oxidative stress, inflammatory markers, liver enzymes, blood glucose, and increased antioxidant capacity. They significantly reduced mRNA levels of proapoptotic markers ( CHOP , caspase-9 , and NF-κB ) and increased GRP78 , XBP1s , and BCL2 expression, suggesting attenuation of apoptosis and modulation of UPR‐related gene expression. Conclusion: D. aucheri extract may modulate UPR‐ and apoptosis‐related pathways, alleviate ERS, and potentially reduce diabetes‐associated complications in STZ‐induced diabetic rats. However, further mechanistic and translational studies are required to confirm these findings and evaluate their clinical relevance.

  • Chlorella vulgaris and Lactobacillus casei Improve Liver Dysfunction via UPR and Autophagy in High-Fat Diet-Induced NAFLD in Mice

    by Farhad Koohpeyma, Roozbeh Kiani, Morvarid Siri, Nima Montazeri-Najafabady, Zahra Moayedfard, Naeimehossadat Asmarian, Pooneh Mokarram, Negar Azarpira, Forough Saki, Mesbah Shams, et al.

    Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), with no approved pharmacological treatments. Autophagy and endoplasmic reticulum (ER) stress are key pathways in NAFLD pathogenesis. This study investigates the therapeutic potential of Chlorella vulgaris (CV) microalgae and Lactobacillus casei (LBC) probiotics on liver function in a high-fat diet (HFD)-induced NAFLD mouse model. Male C57BL/6 mice were divided into five groups: control, NAFLD (HFD for 8 weeks), NAFLD + CV, NAFLD + LBC, and NAFLD + CV + LBC. Liver enzymes, lipid profiles, oxidative stress markers, inflammatory cytokines, and gene expression related to UPR, autophagy, and apoptosis were measured, along with stereological and histopathological analyses. CV and LBC treatments significantly improved serum ALT, AST, cholesterol, LDL, triglycerides, MDA, LPS, TNF-α, IL-6, and CRP while modulating UPR (GRP78, IRE1α, PERK, ATF6), autophagy (Beclin1, P62, LC3-IIB), and apoptosis (Caspase-3, BAX/Bcl-2 ratio) pathways. In treated groups, stereological analysis showed reduced liver weight, volume, and histopathological damage (p < 0.05). The combination of Chlorella vulgaris (CV) and Lactobacillus casei (LBC) enhanced liver function, reduced oxidative stress, and modulated the expression of UPR, autophagy, and apoptosis pathways at the mRNA level in NAFLD mice, leading to improved overall outcomes (p < 0.05). Chlorella vulgaris and Lactobacillus casei exhibit therapeutic potential for NAFLD, warranting further investigation for clinical applications.


  • Open Access

    Septic Gangrene and Thrombophlebitis Following Leech Therapy in a Patient with Undiagnosed Arterial Occlusive Disease: A Case Report

    by Mohadeseh Ostovar, Ahmad Hosseinzadeh, Mojtaba Heydari, Mahsa Moghadam, Mesbah Shams

    Different side effects have been reported for leech therapy, such as local itching, skin reactions, infection, bleeding disorders, and anemia. The present study described a rare and lethal adverse event following leech therapy.

  • Open Access

    Evaluation of the Effects of Dorema aucheri (Bilhar) Hydroalcoholic Extract on Wound Healing of Streptozotocin‐Induced Diabetic Rats: A Stereological Study

    by Forough Saki, Aliakbar Banihashemi, Farhad Koohpeyma, Sanaz Dastghaib, Alireza Raeisi, Mesbah Shams

    Background and Purpose: One of the most common complications of diabetes is impaired healing of diabetic wounds. Given the antidiabetic and antimicrobial effects of the Dorema aucheri plant, the present study was conducted to determine the impact of the alcoholic extract of this plant on the healing of full‐thickness diabetic wounds in male rats. Materials and Methods: In this experimental study, 48 male rats were randomly divided into 6 groups: control wound, diabetic wound, diabetic wound with carboxymethylcellulose base gel, and diabetic wounds with the combination of D. aucheri extract with percentages of 2%, 5%, and 10%. The wound in all groups was the full thickness of the skin. The drugs were administered topically, once daily, for 14 days. Also, to measure the percentage of wound healing, we took photographs of the samples on Days 0, 3, 7, and 14. Finally, skin samples were taken from the wound repair site for stereological evaluation. Results: In comparison to the other groups, the group treated with 5% D. aucheri extract showed a better healing speed, volume of re‐epithelialization, density of collagen deposition, and neovascularization ( p ≤ 0.05). The fibroblast number density, collagen density, and hair follicle volume densities were all lower in the 10% D. aucheri ‐treated group than in the other groups ( p ≤ 0.001). Conclusion: The hydroalcoholic extract of the D. aucheri plant, particularly at a concentration of 5%, has beneficial effects on the healing process of diabetic wounds.

  • Open Access

    "Protective effects of artichoke extract and Bifidobacterium longum on male infertility in diabetic rats"

    by Zahra Ansari, Mohammad Hasan Maleki, Fatemeh Roohy, Zahra Ebrahimi, Mesbah Shams, Pooneh Mokaram, Zahra Zamanzadeh, Zahra Hosseinzadeh, Farhad Koohpeyma, Sanaz Dastghaib


  • Open Access

    Exploring the Therapeutic Potential of β-Hydroxybutyrate (BHB) in Clear Cell Renal Cell Carcinoma: A Journey into Fat Browning, Autophagy, and Tumor Slimming

    by Roya Rezaei, Asra Abdali Larki, Rosa Hosseinzadegan, Zahra Dashti, Saba Tarkashvand, Reihaneh Akhoondi, Morvarid Siri, Mesbah Shams, Alireza Monsef, Sanaz Dastghaib

    This study delves into the therapeutic potential of β-hydroxybutyrate (BHB) in clear cell renal cell carcinoma (ccRCC), a cancer known for its complex pathogenesis and resistance to conventional treatments. The research specifically explores the impact of BHB on cell viability, autophagy induction, and lipid metabolism in Caki-1 cells. The findings reveal that BHB significantly reduces ccRCC cell viability, particularly under low-glucose conditions. The combination of glucose and BHB treatment activates autophagy pathways, as evidenced by increased expression of autophagy-related genes (Beclin-1, LC3IIβ, and ATG5) and decreased expression of P62 after 48 and 72hours. Moreover, the combined therapy enhances lipid metabolism, as indicated by elevated expression of PGC-1 and UCP-1, along with upregulation of ACSL3 and CPT1A, which are associated with lipid droplet formation and facilitate lipid breakdown within cells. The study concludes that BHB holds promise as a therapeutic agent for ccRCC, targeting abnormal lipid metabolism, inducing autophagy-mediated cell death, and promoting fat browning. The results suggest potential avenues for precision-guided nutritional therapies in ccRCC treatment, highlighting the innovative role of BHB in addressing the challenges posed by this cancer.


  • Open Access

    Proton-pump inhibitor-induced bone loss is preventable by concomitant use of a long-acting somatostatin analogue

    by Farhad Koohpeyma, Samaneh Taghiyan, Mesbah Shams

    Objective(s): Long-term consumption of pump inhibitors causes osteoporosis. Some possible mechanisms are gastrin over-secretion and hypochlorhydria. Octreotide is a somatostatin analog that inhibits the secretion of many hormones such as gastrin. This study aimed to assess the effects of pantoprazole on the bone when used with octreotide in an animal model.Materials and Methods: Forty-eight male Wistar rats were randomly assigned into 4 groups: A) pantoprazole 3 mg/Kg/day orally; B) Sandostatin LAR 1 mg/month intramuscular injection; C) Pantoprazole and Sandostatin LAR; and D) Control group. After 90 days of the experiment, bone densitometry was done and serum and urine samples were collected for analysis.Results: The results indicated a significant decrease in the global, spine, femur, and tibia bone mineral density (BMD) and bone mineral content (BMC) in the pantoprazole group compared to the control group (P<0.05). There was a significant increase in the levels of PTH, gastrin, and alkaline phosphatase (ALP) in the pantoprazole group compared to the control group (P<0.05). There was no significant difference in the serum levels of gastrin, PTH, ALP, and also BMD in the rats that received sandostatin+ pantoprazole or sandostatin alone, compared to the control group.Conclusion: This study showed that the pantoprazole-induced bone loss, through elevation of serum gastrin and PTH, was preventable by concomitant use of a long-acting somatostatin analog.


  • The Effects of Ginger ( Zingiber Officinale Roscoe) on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Placebo-Controlled Clinical Trial

    by Parissa Sadat Ghoreishi, Mesbah Shams, Majid Nimrouzi, Mohammad M. Zarshenas, Kamran Bagheri Lankarani, Ebrahim Fallahzadeh Abarghooei, Mozaffar Talebzadeh, Mohammad Hashem Hashempur

    Nonalcoholic fatty liver disease (NAFLD) is a prominent etiological factor for liver cirrhosis worldwide. It is frequently associated with obesity, diabetes, dyslipidemia, and hypertension. The objective of this study is to assess the efficacy and safety of ginger (Zingiber officinale Roscoe) supplementation in patients with type 2 diabetes mellitus (T2DM) who have NAFLD. In a two-arm, double-blind, placebo-controlled clinical trial, seventy-six patients diagnosed with both T2DM and NAFLD were randomly assigned to receive either ginger powder capsules (1000 mg, twice daily) or placebo capsules (administered in the same manner) for a period of three months. Anthropometric measurements, blood pressure readings, biochemical profiles, and imaging parameters were assessed before and after the intervention. Safety measures were also evaluated. In both the ginger and placebo groups, there was a significant reduction in mean body mass index (BMI), waist and hip circumferences, as well as liver transaminase levels. Moreover, significant improvements in mean systolic and diastolic blood pressures were observed in the ginger group (p = 0.02 and < 0.0001, respectively). Within the ginger group, there was a decrease in serum insulin levels and insulin resistance (HOMA-IR) (p = 0.002 and 0.004, respectively). Furthermore, the ginger group exhibited an improvement in serum HDL-cholesterol level (p = 0.01). However, there were no significant changes in the assessed inflammatory markers or the indices obtained from fibroscan imaging, including steatosis percent and controlled attenuation parameter. This study demonstrates that ginger supplementation can significantly improve mean systolic and diastolic blood pressures. However, it does not have a significant impact on inflammatory markers or fibroscan imaging indices. Nonetheless, the three-month use of ginger improves serum insulin level, insulin resistance (HOMA-IR), and HDL-cholesterol level compared to baseline values. Further investigations with longer durations and larger sample sizes are recommended.


  • Open Access

    Association between Nontraditional Risk Factors and Calculated 10-Year Risk of Atherosclerotic Cardiovascular Disease in a Large General Population: Based on the Pars Cohort Study

    by Seyyed Mojtaba Ghorashi, Pooria Ahmadi, Reza Shahnazar Nezhad Khalesi, Amir Fazeli, Hossein Molavi Vardanjani, Alireza Salehi, Negar Omidi, Mesbah Shams, Amirhossein Babaei

    Background: While the traditional risk factors of atherosclerotic cardiovascular disease (ASCVD) have been well-established, the evolving role of nontraditional risk factors is not apparent. This study aimed to evaluate the association between nontraditional risk factors and the calculated 10-year ASCVD risk in a general population. Methods: This cross-sectional study was conducted using the Pars Cohort Study data. All inhabitants of the Valashahr district in southern Iran, aged 40–75 years, were invited (2012-2014). Patients with a history of cardiovascular disease (CVD) were excluded. The demographic and lifestyle data were collected using a validated questionnaire. Multinomial logistic regression analysis was used to evaluate the association between the calculated 10-year ASCVD risk and the nontraditional risk factors of CVD, including marital status, ethnicity, educational level, tobacco and opiate consumption, physical inactivity, and psychiatric disorders. Results: Of 9264 participants (mean age =52.2±9.0 y; 45.8% male), 7152 patients met the inclusion criteria. In total, 20.2%, 7.6%, 36.3%, 56.4%, and 46.2% of the population were cigarette smokers, opiate consumers, tobacco consumers, ethnically Fars, and illiterate, respectively. The prevalence rates of low, borderline, and intermediate-to-high 10-year ASCVD risks were 74.3%, 9.8%, and 16.2%, respectively. In multinomial regression, anxiety (adjusted odds ratio [aOR], 0.58; P<0.001) was significantly associated with a lower ASCVD risk, whereas opiate consumption (aOR, 2.94; P<0.001) and illiteracy (aOR, 2.48; P<0.001) were significantly associated with a higher ASCVD risk. Conclusion: Nontraditional risk factors are associated with the 10-year ASCVD risk and, thus, might be considered besides traditional ones for ASCVD in preventive medicine and health policies.